ST6GAL1 and hepatocellular carcinoma: In the same study, converse experiments demonstrated that targeting ST6Gal1 in the metastatic HCC cell line MHCC97H decreased invasion as well as expression of PI3K p110α and phospho-AKT (Zhao et al., 2014).